Skip to main content
Premium Trial:

Request an Annual Quote

The Cancer Cure: It Won't Be Cheap and It Won't Be Easy

Yesterday's New York Times included a series of letters from readers responding to the paper's op-ed on dealing with cancer. Respondents hail from the Fox Chase Cancer Center and the Public Health Research Institute, among others.

An excerpt from one letter:


Scientific discovery that addresses underlying disease mechanisms requires a union of physicians and academic researchers to develop novel approaches that can adroitly explore areas like host genetics while looking out for new etiologic agents.

Unfortunately, such high-risk science that challenges prevailing doctrine has been a casualty in a federal fiscal environment where biomedical financing is approaching 1 in 10 grants.

 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.